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Radioiodinated human platelet-derived growth factor (12SI-PDGF), and unlabeled human (Hu), bovine 
(Bo), and porcine (PO) PDGF were used to study PDGF receptors in human term placental membrane prep- 
arations. The binding of 1251-Hu-PDGF was inhibited by unlabeled preparations. Half-maximal occupancy 
of the binding sites occurred at 7-9 nM of Hu-, Bo- or PO-PDGF. Scatchard analysis of the binding data 
indicated a single class of receptors having a & value of about 1 .l-1.2 x 10-i” M. Thus, the sensitive radi- 
oreceptor assay does not detect any species pecificity of PDGF. 
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1. INTRODUCTION 
Platelet-derived growth factor (PDGF) is a pro- 
tein of A4, 30000, composed of two disulphide- 
linked subunit chains. The dimer structure of 
PDGF appears to be important for its biological 
effects. Human (Hu) PDGF exists as a 
heterodimer composed of A and B chains of ap- 
proximately equal size [ 11. The B chain is almost 
identical to part of the v-sis oncogene product of 
simian sarcoma virus (SSV) [2]. Porcine (PO) 
PDGF exists as a homodimer of B chains [3]. The 
structure of bovine (Bo) PDGF is not clear as yet 
[41. 
PDGF is a potent mitogen for mesenchymal cells 
[5,6]. It has been shown that PDGF, like other 
tissue hormones, exerts its biological effects 
through interaction with specific, high-affinity 
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receptors associated with its target cells. Recently, 
the structure of the receptor for PDGF has been 
described. It contains a single stretch of predo- 
minantly hydrophobic amino acids (transmem- 
brane region), an amino-terminal extracellular 
domain (the ligand-binding region) and an intra- 
cellular domain carrying the enzymatic phospho- 
transferase activity [7]. At 10e9 M or less, PDGF 
binding to the receptors stimulates replication of 
fibroblasts, glial, endothelial and other connective 
tissue cells in vitro [8-121. Here, we show that 
preparations of human term placenta express high- 
affinity membrane protein receptors binding Hu-, 
Bo- and PO-PDGF. 
2. MATERIALS AND METHODS 
Hu-PDGF and Bo-PDGF were purified as 
described [4,13]. The final products were 90% 
pure as estimated from analytical SDS- 
polyacrylamide gel electrophoresis. PO-PDGF was 
purified using ion-exchange chromatography on 
DEAE-Sephadex A-50 and CM-Sephadex C-50, 
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gel filtration on Sephadex G-100 and 
chromatography on poly(U)-Sepharose. It was 
50% pure after the last step of purification (Narc- 
zewska and Czyrski, unpublished). Hu- and Bo- 
PDGF stimulated Balb/c 3T3 and human em- 
bryonic fibroblast proliferation in cultures at con- 
centrations of OS-l.5 ng/ml (0.05-0.15 nM). 
Purified Hu-PDGF (approx. 500000 mitogenic 
units/ml protein [13]) was labeled with “‘1 ac- 
cording to Hunter and Greenwood [14]. Briefly, 
5 pg PDGF was labeled with 0.5 mCi 12’I. 12?- 
PDGF was separated from unbound radioactivity 
on a Sephadex G-25 column as described by Heldin 
et al. [8]. The specific activity was approx. 
15 000 cpm per ng protein. 
Gel electrophoresis of 1251-PDGF was perform- 
ed according to Laemmli [ 151, using a gel concen- 
tration of 10%. After slicing, gels were assayed for 
radioactivity in a gamma spectrometer. The 
I mobilities of the M, markers were determined by 
protein staining. 
Human placental membranes were isolated from 
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Fig. 1. Electrophoresis of ‘?-PDGF used as a tracer in 
the radioreceptor assay (RRA). PDGF was labeled with 
r*‘I (Institute of Atomic Energy, Swierk, Poland; 
4.32 GBq/ml). 100000 cpm was applied to analytical 
SDS-polyacrylamide gel electrophoresis under non- 
reducing conditions. Standard proteins from Serva were 
Fig.2. Concentration dependence of ‘2sI-labeled PDGF 
binding to human placental membrane protein 
preparations. Membrane proteins were incubated for 2 h 
at 37°C with various amounts of unlabeled (m) Hu-, (A) 
Bo- or ( + ) PO-PDGF and 15 ng ‘251-Hu-PDGF as 
described in section 2. After washing and centrifugation 
the membrane-associated radioactivity was determined 
in a gamma spectrometer (Beckman 4000). Binding has 
been plotted with correction for the nonspecific binding, 
which was taken as radioactivity bound in the presence 
of a 50-fold molar excess of unlabeled Hu-, Bo- or 
used. PO-PDGF. 
fresh-frozen term human placenta by differential 
centrifugation as described by Hock and 
Hollenberg [ 161. 
Placental membrane aliquots (200 pg protein) 
were incubated for 2 h at 37°C with gentle shaking 
in binding medium (phosphate-buffered saline, 
PBS; pH 7.2) containing various concentrations of 
unlabeled Hu-, Bo- or PO-PDGF. The total 
volume of the binding assay mixture was 200 ~1. 
Experiments were performed in the presence of 
0.1% bovine albumin. After 2 h labeled Hu-PDGF 
(200000 cpm) was added and the binding was con- 
tinued under the same conditions. Experiments 
were terminated by rapid centrifugation of the in- 
cubation mixture followed by three washes of the 
pellets with ice-cold PBS containing 1% bovine 
albumin. Nonspecific binding to membrane pro- 
tein, estimated from the amount of binding in the 
presence of a 50-fold molar excess of unlabeled 
Hu-, Bo- or PO-PDGF, was usually between 5 and 
10% of the total binding. 
3. RESULTS AND DISCUSSION 
All fractions obtained after chromatography of 
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Fig.3. Scatchard plot of the results shown in fig.2, illustrating the binding of ‘251-labeled Hu-PDGF to human placental 
membrane receptors. Preincubation with unlabeled: Hu-PDGF (A), Bo-PDGF (B), PO-PDGF (C). 
labeled PDGF on the Sephadex G-25 column were 
subjected to polyacrylamide gel electrophoresis. 
We have found that the fractions containing a pro- 
tein of Mr about 34000 are able to bind to the 
placental membrane receptors. Fig.1 shows an 
electrophoresis run of “‘I-Hu-PDGF which has 
been used as tracer in our experiments. 
Incubation of the placental membrane proteins 
with various concentrations of Hu-, Bo- or Po- 
PDGF demonstrated a saturable binding reaction 
(fig.2). A Scatchard plot [17] of the binding data 
indicated a single class of receptors. The apparent 
& values were 1.2 X lo-” M for Hu- and Po- 
PDGF and 1 .l x lo-” M for Bo-PDGF. 1 mg of 
the receptor protein was shown to bind approx. 
7000 fmol PDGF (fig.3A-C). 
Binding of “‘1-Hu-PDGF was a saturable reac- 
tion. Scatchard [17] analysis at equilibrium showed 
only one class of high-affinity binding sites. The 
binding of ‘*‘I-Hu-PDGF to receptors was in- 
hibited by unlabeled Hu-, Bo- or PO-PDGF. The 
results suggest hat the term human placenta is a 
rich source of PDGF receptors for the estimation 
of free PDGF in blood preparations, tissue fluids, 
cell extracts, etc. Anionic fractions of the platelet 
lysate containing transforming growth factor fl 
[4,18] or human interferon cy did not compete with 
‘*‘I-Hu-PDGF for receptor occupancy even at 
large excess of the preparations (not shown). 
We could not determine which cells of the 
placenta possess the receptors for PDGF. The 
receptors are probably expressed on the surface of 
different cells as suggested by others [lo-121 but 
their structure appears to be similar. 
The placental membrane receptors do not 
discriminate between Hu-, Bo- or PO-PDGF. 
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